Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by S. Virabhak
Pcn188 - Assessing the Robustness of a Cost-Effectiveness Analysis of Lenvatinib Versus Sorafenib in Unresectable Hepatocellular Carcinoma in Japan
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Lenvatinib and Its Use in the Treatment of Unresectable Hepatocellular Carcinoma
Future Oncology
Medicine
Cancer Research
Oncology
Sorafenib for the Treatment of Unresectable Hepatocellular Carcinoma
Biologics: Targets and Therapy
Oncology
Immunology
Gastroenterology
Pharmacology
Rheumatology
Allergy
Pcn168 - Cost-Effectiveness of Sorafenib in the Treatment of Hepatocellular Carcinoma: A Systematic Review
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Overall Survival in Response to Sorafenib Versus Radiotherapy in Unresectable Hepatocellular Carcinoma With Major Portal Vein Tumor Thrombosis: Propensity Score Analysis
BMC Gastroenterology
Medicine
Gastroenterology
Retrospective Analysis of Transarterial Chemoembolization and Sorafenib in Chinese Patients With Unresectable and Recurrent Hepatocellular Carcinoma
Oncotarget
Oncology
Sorafenib Continuation or Discontinuation in Patients With Unresectable Hepatocellular Carcinoma After a Complete Response
Oncotarget
Oncology
Sorafenib in Hepatocellular Carcinoma
Clinical Medicine. Therapeutics
Yttrium-90 Radioembolization Versus Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Comparative Analysis
HPB
Hepatology
Gastroenterology
Efficacy and Adverse Events of Transcatheter Arterial Chemoembolization in Combination With Sorafenib in the Treatment of Unresectable Hepatocellular Carcinoma
Molecular and Clinical Oncology
Cancer Research
Oncology
